Tan, Winston

Safety and efficacy of durvalumab (MEDI4736), an anti–programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer

Massard, C., Gordon, M. S., Sharma, S., Rafii, S., Wainberg, Z. A., Luke, J., Curiel, T. J., Colon-Otero, G., Hamid, O., Sanborn, R. E., et al. (2016) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments

Cited by 840

Oncologists’ Attitudes and Practice of Addressing Diet, Physical Activity, and Weight Management With Patients With Cancer: Findings of an ASCO Survey of the Oncology Workforce

Ligibel, J. A., Jones, L. W., Brewster, A. M., Clinton, S. K., Korde, L. A., Oeffinger, K. C., Bender, C. M., Tan, W., Merrill, J. K., Katta, S., et al. (2019) · Journal of Oncology Practice

Cancer Risks and FactorsObesity and Health Practices

Cited by 126

A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer

Ames, S. C., Tan, W. W., Ames, G. E., Stone, R. L., Rizzo, T. D., Crook, J. E., Williams, C. R., Werch, C. E., Clark, M. M., & Rummans, T. A. (2011) · Psycho-Oncology

Cancer survivorship and careProstate Cancer Diagnosis and Treatment

Cited by 21